CNM — Core & Main Income Statement
0.000.00%
Last trade - 00:00
- $10.37bn
- $12.84bn
- $6.70bn
- 79
- 57
- 82
- 84
2020 February 2nd | 2021 January 31st | 2022 January 30th | 2023 January 29th | 2024 January 28th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,389 | 3,642 | 5,004 | 6,651 | 6,702 |
Cost of Revenue | |||||
Gross Profit | 789 | 878 | 1,280 | 1,795 | 1,818 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,233 | 3,457 | 4,630 | 5,876 | 5,962 |
Operating Profit | 155 | 186 | 374 | 775 | 740 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 41.7 | 46.4 | 276 | 709 | 659 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.2 | 44.5 | 225 | 581 | 531 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 41.2 | 44.5 | 166 | 366 | 371 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 41.2 | 44.5 | 210 | 525 | 489 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.171 | 0.185 | 1.07 | 2.15 | 2.19 |
Dividends per Share |